Discontinued — last reported Q3 '19
An increase indicates portfolio expansion and potential for broader market reach, whereas a decrease often signals strategic pruning of low-margin or legacy products to improve operational focus.
This metric tracks the total count of distinct product stock-keeping units (SKUs) or therapeutic offerings currently con...
Comparable to 'Number of Commercialized Products' or 'Portfolio Size' metrics used by life sciences companies to measure operational breadth.
vtrs_segment_net_sales_number_of_products